Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN Trial
Background. An exploratory subanalysis of the ODIN trial was performed to evaluate the efficacy of darunavir/ritonavir (DRV/r) 800/100 mg OD versus 600/100 mg BID in patients who were NNRTI-experienced but PI-naïve. Methods. ODIN was a phase III, 48-week study comparing DRV/r OD versus BID in 590 tr...
Saved in:
Main Authors: | Anna Maria Geretti, Mathe Moeketsi, Ralph Demasi, Yvon van Delft, Perry Mohammed |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | AIDS Research and Treatment |
Online Access: | http://dx.doi.org/10.1155/2015/962574 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Effectiveness of Darunavir 1,200 mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced Patients
by: James M. Mikula, et al.
Published: (2013-01-01) -
Validation of Simultaneous Quantitative Method of HIV Protease Inhibitors Atazanavir, Darunavir and Ritonavir in Human Plasma by UPLC-MS/MS
by: Tulsidas Mishra, et al.
Published: (2014-01-01) -
Once-Daily Dosing of Aminoglycosides
by: William A Craig
Published: (1994-01-01) -
Quality of Life in Yoga Experienced and Yoga Naïve Asian Indian Adults with Obesity
by: Shirley Telles, et al.
Published: (2019-01-01) -
HIV model incorporating differential progression for treatment-naive and treatment-experienced infectives
by: Esther Chigidi, et al.
Published: (2009-05-01)